Emerging therapeutic agents for genitourinary cancers
The treatment of genitourinary malignancies has dramatically evolved over recent years. Renal cell carcinoma, urothelial carcinoma of the bladder, and prostate adenocarcinoma are the most commonly encountered ...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Kevin Zarrabi, Azzam Paroya and Shenhong Wu Tags: Review Source Type: research
More News: Adenocarcinoma | Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Hematology | Kidney Cancer | Renal Cell Carcinoma